| Document Date: 2015-04-27 00:54:36
Open Document File Size: 74,19 KBShare Result on Facebook
City Fairfield / Mountain View / / Company Amarin Pharma Inc. / Corporate Creations Network Inc. / Plaintiff VIVUS Inc. / Synthon Pharmaceuticals Inc. / Doctor Reddy’s Laboratories Ltd. / Boehringer Ingelheim Pharma GmBH & Co. KG / TEVA PHARMACEUTICALS USA INC. / Helsinn Healthcare S.A. / NEW JERSEY VIVUS INC. / Otsuka Pharmaceutical Co. Ltd. / TEVA PHARMACEUTICAL INDUSTRIES LTD. / VIVUS / Novo Nordisk Inc. / Therapeutics Corp. / Teva Pharmaceutical Industries / Lizza William C. Baton SAUL EWING LLP / / Country United States / Israel / / / Event FDA Phase / Patent Issuance / M&A / Legal Issues / / Facility Charles M. Lizza William C. Baton SAUL EWING LLP One Riverfront Plaza / / IndustryTerm active pharmaceutical ingredients / pharmaceutical compositions containing combinations / pharmaceutical products / drug products / / MedicalCondition obesity / / Organization United States Food and Drug Administration / United States Patent and Trademark Office / / Person Thomas Najarian / Cherry Hill / Peter Y. Tam / Leland F. Wilson / / / Position wholesaler / / Product topiramate / Proposed Product / QSYMIA® / / ProvinceOrState New Jersey / Pennsylvania / Delaware / California / New / / Region North Wales / /
SocialTag |
Case 2:15-cvSRC-CLW Document 1 FiledPage 1 of 152 PageID: 1 Charles M. Lizza William C. Baton SAUL EWING LLP One Riverfront Plaza, Suite 1520